N/A
N=48
Nalox-Comm: Naloxone Communication Training for Pharmacists
Naloxone
Bottom Line
View on ClinicalTrials.gov: NCT04677387 ↗Enrolled (actual)
48
Serious AEs
0.0%
Results posted
Jun 2024
Primary outcome: Primary: Change in Naloxone Dispensing Rate Over a 6-month Period — .0073; .0041 number of naloxone products dispensed — p=0.473
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Nalox-comm Training Module (Behavioral); Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of North Carolina, Chapel Hill
- Primary completion
- Jul 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Naloxone Dispensing Rate Over a 6-month Period |
.0073; .0041 | 0.473 |
| SECONDARY Mean Willingness to Dispense Naloxone Score |
3.72; 3.57; 3.64; 3.84; 3.47; 3.69 | .007 sig |
| SECONDARY Mean Naloxone Counselling Self-Efficacy Score |
3.08; 2.74; 3.19; 3.4; 3.28; 3.51 | .002 sig |
| SECONDARY Mean Pharmacist Quality of Non-verbal Communication Score |
3.31; 3.5; 3.62; 4.11 | 0.169 |
Summary
This is a pilot Randomized Controlled Trial (RCT) in which 120 pharmacists will be randomized to an experimental or control group and data on naloxone dispensing and secondary outcomes will be collected over the course of the RCT.
Eligibility Criteria
Inclusion Criteria
- currently work at a pharmacy that stocks naloxone;
- currently work at a rural community pharmacy;
- are at least 18 years of age; and
- speak English.
Exclusion Criteria
- Non-staff pharmacists such as pharmacy "floaters" or fill-in pharmacists will not be eligible to participate.
Data sourced from ClinicalTrials.gov (NCT04677387). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.